Amicus Therapeutics, Inc., is a blopharmaceutical company that develops drugs for the treatment of various diseases, including Parkinson's disease. Amicus Therapeutics reported the following financial data (in thousands) for three recent years: a. Determine the monthly cash expenses for Year 3, Year 2, and Year 1 (in thousands). Round to one decimal place. Year3:Year2:Year1:$$$permonthpermonthpermonth b. Determine the ratio of cash to monthly cash expenses for Year 3, Year 2 , and Year 1 as of December 31. Round to one decimal place. c. Based on (a) and (b), which of the following statements is correct, 1. Amicus has been able to support its operations by issuing additional stock. However, its negative cash flows have increased from Year 1 to Year 3